- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Very Small Cerebral Lesions May Increase Risk of Stroke
Cerebral lesions of 3 mm or smaller, detected by MRI, may increase risk of stroke and death.
Magnetic resonance imaging detects very small cerebrovascular lesions, which may be associated with increased risks for stroke and death, according to a study published in the Annals of Internal Medicine.
Researchers from Mississippi, Maryland, Washington, Minnesota, and North Carolina sought to determine stroke risks associated with brain lesions 3 mm or smaller, which are typically ignored by clinicians, and white matter hypersensitivities (WMHs).
A total of 1,884 subjects, aged 50 to 73, with no prior history of stroke, participated in the study. All underwent MRI of the brain. The researchers evaluated:
• Lesion size
• WMH score (scale of 0 to 9)
• Incident stroke
• All-cause mortality
• Stroke-related mortality
Follow-up was an average of 14.5 years.
The results showed that the stroke risk was tripled among patients who had lesions that were 3 mm or smaller, compared with patients who had no lesions seen by MRI. There were:
• 157 clinical strokes (89% were ischemic strokes)
• 50 stroke-related deaths
• 576 all-cause deaths
The researchers concluded that these very small cerebrovascular lesions may be associated with an increased risk of stroke and death, but more study is needed.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
